Trekka Therapeutics, Inc.
Eagan, MN
- UEI
- DQNYYX2KMPK6
- CAGE
- 8TJP9
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 3218 Red Oak Dr, Eagan, MN 55121, USA
- Website
- trekkatherapeutics.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Nanodroplet infused analgesic-wafer for transmucosal opioid-free treatment of subacute oral pain - summary over 2… | National Institute of Dental and Craniofacial Research | $1,109,819 | |
| A novel melanoma vaccine based on a shared neoantigen and a liquid polymer platform - abstract despite the dramatic… | National Cancer Institute | $1,095,604 |
Quick answers
What is Trekka Therapeutics, Inc.'s UEI?
Trekka Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is DQNYYX2KMPK6.
What is Trekka Therapeutics, Inc.'s CAGE code?
Trekka Therapeutics, Inc.'s CAGE code is 8TJP9.
Where is Trekka Therapeutics, Inc. located?
Trekka Therapeutics, Inc.'s physical address in SAM.gov is 3218 Red Oak Dr, Eagan, MN 55121, USA.
Is Trekka Therapeutics, Inc. registered in SAM.gov?
Yes. Trekka Therapeutics, Inc.'s SAM.gov registration is active through July 20, 2027.
What is Trekka Therapeutics, Inc.'s most recent federal award?
Trekka Therapeutics, Inc.'s most recent federal grant award is Nanodroplet infused analgesic-wafer for transmucosal opioid-free treatment of subacute oral pain - summary over 2… (R41DE034604), from National Institute of Dental and Craniofacial Research, on September 4, 2025.
On GovTribe
See Trekka Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors